Abstract
Managing pharmacotherapy for patients in palliative care (PC) presents a challenge for healthcare professionals. The concurrent use of medications to control signs and symptoms, as well as to prevent clinical deterioration associated with morbidities and comorbidities, contributes to the inappropriate use of these healthcare technologies. Furthermore, polypharmacy contributes to the incre…